Inventor · disambiguated record
Nicholas Scorah
Also filed as: SCORAH NICHOLAS
16 granted patents·7 pending applications·136 citations·filing 2005–2021
92Inventor score
Files withTAKEDA PHARMACEUTICALS CO7DONG QING4TAKEDA PHARMACEUTICAL4BROWN JASON W2CARDURION PHARMACEUTICALS LLC2
Top patents by PatentIndex Score
23 records- 0196US8119655B2Kinase inhibitorsDONG QING·Filed 2006·Granted Feb 21, 2012·59 cites·17 claims
- 0292US7713973B2Kinase inhibitorsTAKEDA PHARMACEUTICAL·Filed 2005·Granted May 11, 2010·21 cites·31 claims
- 0391US10543212B2Substituted amines for treating cardiac diseasesCARDURION PHARMACEUTICALS LLC·Filed 2018·Granted Jan 28, 2020·10 cites·11 claims
- 0489US8288536B2Kinase inhibitorsDONG QING·Filed 2010·Granted Oct 16, 2012·14 cites·8 claims
- 0586US8268819B2Hexahydrooxazinopterine compoundsJIN BOHAN·Filed 2012·Granted Sep 18, 2012·11 cites·8 claims
- 0685US8791107B2N-substituted oxazinopteridines and oxazinopteridinonesCHANG EDCON·Filed 2012·Granted Jul 29, 2014·10 cites·13 claims
- 0784US8163755B2Hexahydrooxazinopterine compoundsJIN BOHAN·Filed 2010·Granted Apr 24, 2012·9 cites·17 claims
- 0879US9402841B2Pyridinyl and fused pyridinyl triazolone derivativesTAKEDA PHARMACEUTICALS CO·Filed 2014·Granted Aug 2, 2016·1 cites·36 claims
- 0975US9801872B2Pyridinyl and fused pyridinyl triazolone derivativesTAKEDA PHARMACEUTICALS CO·Filed 2016·Granted Oct 31, 2017·1 cites·33 claims
- 1071US2019224190A1Pyridinyl and fused pyridinyl triazolone derivativesTAKEDA PHARMACEUTICALS CO·Filed 2019·Application pending·0 cites
- 1167US10307414B2Pyridinyl and fused pyridinyl triazolone derivativesTAKEDA PHARMACEUTICALS CO·Filed 2017·Granted Jun 4, 2019·0 cites·11 claims
- 1262US2022227830A1Qd dosing of gip receptor agonist peptide compounds and uses thereofTAKEDA PHARMACEUTICALS CO·Filed 2021·Application pending·0 cites
- 1360US8278450B2Kinase inhibitorsBROWN JASON W·Filed 2008·Granted Oct 2, 2012·0 cites·3 claims
- 1457US8293901B2MAPK/ERK kinase inhibitorsDONG QING·Filed 2007·Granted Oct 23, 2012·0 cites·7 claims
- 1556US2023143604A1Qw dosing of gip receptor agonist peptide compounds and uses thereofTAKEDA PHARMACEUTICALS CO·Filed 2021·Application pending·0 cites
- 1656US2009156557A1Kinase inhibitorsTAKEDA SAN DIEGO INC·Filed 2008·Application pending·0 cites
- 1755US11197858B2Substituted amines for treating cardiac diseasesCARDURION PHARMACEUTICALS LLC·Filed 2020·Granted Dec 14, 2021·0 cites·8 claims
- 1853US9045496B2N-substituted oxazinopteridines and oxazinopteridinonesTAKEDA PHARMACEUTICAL·Filed 2014·Granted Jun 2, 2015·0 cites·8 claims
- 1951US2009312288A1Kinase inhibitorsTAKEDA PHARMACEUTICAL·Filed 2009·Application pending·0 cites
- 2050US2012252761A1Kinase inhibitorsBROWN JASON W·Filed 2012·Application pending·0 cites
- 2144US8318939B2Kinase inhibitorsDONG QING·Filed 2010·Granted Nov 27, 2012·0 cites·7 claims
- 2242US2010160633A1Kinase inhibitorsTAKEDA PHARMACEUTICAL·Filed 2010·Application pending·0 cites
- 2334US9598424B2Heteroarylamide inhibitors of TBK1TAKEDA PHARMACEUTICALS CO·Filed 2015·Granted Mar 21, 2017·0 cites·15 claims
Join the waitlist — get patent alerts
Get an alert when Nicholas Scorah files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →